48th week of 2019 patent applcation highlights part 9 |
Patent application number | Title | Published |
20190358218 | 6-ALKYNYL-PYRIDINE DERIVATIVES | 2019-11-28 |
20190358219 | TERNARY CONJUGATE OF ANTITUMOR DRUG, AND SYNTHESIS AND APPLICATION | 2019-11-28 |
20190358220 | INTEGRATOR INHIBITORS AND METHODS FOR THEIR USE | 2019-11-28 |
20190358222 | Increasing Drug Bioavailability In Naltrexone Therapy | 2019-11-28 |
20190358223 | RORGAMMA MODULATORS AND USES THEREOF | 2019-11-28 |
20190358224 | SMALL MOLECULE MODULATORS OF NR2F6 ACTIVITY | 2019-11-28 |
20190358225 | Substituted Fused Heteroaromatic Compounds as Kinase Inhibitors and the Use Thereof | 2019-11-28 |
20190358226 | 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS | 2019-11-28 |
20190358227 | USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE TREATMENT OF CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS | 2019-11-28 |
20190358228 | 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES | 2019-11-28 |
20190358229 | PAC-1 COMBINATION THERAPY | 2019-11-28 |
20190358230 | NOVEL BENZYLAMINO SUBSTITUTED QUINAZOLINES AND DERIVATIVES AS SOS1 INHIBITORS | 2019-11-28 |
20190358231 | Compositions and Methods for Treating Toxoplasmosis, Cryptosporidiosis and Other Apicomplexan Protozoan Related Diseases | 2019-11-28 |
20190358232 | REVERSAL OF FOSFOMYCIN RESISTANCE | 2019-11-28 |
20190358233 | AMINO-PYRROLOPYRIMIDINONE COMPOUNDS AND METHODS OF USE THEREOF | 2019-11-28 |
20190358234 | USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK) | 2019-11-28 |
20190358235 | Therapeutic Combination of a PI3K Inhibitor and a BTK Inhibitor | 2019-11-28 |
20190358236 | THERAPEUTIC USES OF A C-RAF INHIBITOR | 2019-11-28 |
20190358237 | NOVEL BICYCLIC BROMODOMAIN INHIBITORS | 2019-11-28 |
20190358238 | ALLOSTERIC ANTAGONISTS OF GPRC6a AND THEIR USE IN MITIGATING PROTEINOPATHIES | 2019-11-28 |
20190358239 | Enhancers of Cellular Cannibalism for Use to Sensitize Tumors to Radiation Therapy | 2019-11-28 |
20190358240 | HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT | 2019-11-28 |
20190358241 | lsoxazole Compounds | 2019-11-28 |
20190358242 | COMPOSITIONS, KITS, AND METHODS TO INDUCE ACQUIRED CYTORESISTANCE USING STRESS PROTEIN INDUCERS | 2019-11-28 |
20190358243 | VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS | 2019-11-28 |
20190358244 | PHARMACEUTICAL FORMULATION OF 3ALPHA -ETHYNYL-3BETA-HYDROXYANDROSTAN-17-ONE OXIME | 2019-11-28 |
20190358245 | 3-Beta-Hydroxy-5-Alpha-Pregnan-20-One for Use in Medical Treatment | 2019-11-28 |
20190358246 | Metakaryocidal Treatments | 2019-11-28 |
20190358247 | SYNERGISTIC INIHIBITION OF TUMOR CELL PROLIFERATION INDUCED BY COMBINED TREATMENT OF METFORMIN OR METFORMIN ANALOGS AND IRON CHELATORS | 2019-11-28 |
20190358248 | Composition and Methods of Use of Small Molecules as Binding Ligands for the Modulation of Proprotein Convertase Subtilisin/Kexin Type 9(PCSK9) Protein Activity | 2019-11-28 |
20190358249 | Injectable Combination Products Of Fosaprepitant And 5-HT3 Blocker | 2019-11-28 |
20190358250 | RETINOIC ACID RECEPTOR GAMMA AGONISTS TO ATTENUATE ANTHRACYCLINE-INDUCED CARDIOTOXICITY | 2019-11-28 |
20190358251 | PHARMACEUTICAL COMPOSITION AND METHOD FOR REGENERATING MYOFIBERS IN THE TREATMENT OF MUSCLE INJURIES | 2019-11-28 |
20190358252 | STEROID SAPONINS WITH ANTI-CANCER ACTIVITY | 2019-11-28 |
20190358253 | COMPOSITION COMPRISING IMMEDIATE RELEASE AND EXTENDED RELEASE CAPECITABINE | 2019-11-28 |
20190358254 | CYCLIC DINUCLEOTIDES AS AGONISTS OF STIMULATOR OF INTERFERON GENE DEPENDENT SIGNALLING | 2019-11-28 |
20190358255 | PHARMACEUTICAL COMPOSITION CONTAINING SULGLYCOTIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR PREVENTING OR TREATING DRY EYE | 2019-11-28 |
20190358256 | ANTIBIOTIC COMPOSITIONS AND METHODS OF USE | 2019-11-28 |
20190358257 | COMBINED ORGAN AND HEMATOPOIETIC CELLS FOR TRANSPLANTATION TOLERANCE OF GRAFTS | 2019-11-28 |
20190358258 | METHODS FOR ENHANCING PROLIFERATION OF T REGULATORY CELLS | 2019-11-28 |
20190358259 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | 2019-11-28 |
20190358260 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | 2019-11-28 |
20190358261 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | 2019-11-28 |
20190358262 | METHODS FOR MODULATION OF CAR-T CELLS | 2019-11-28 |
20190358263 | Compositions and Methods for Cell Therapy | 2019-11-28 |
20190358264 | METHODS OF TREATING DISEASES ASSOCIATED WITH ILC2 CELLS | 2019-11-28 |
20190358265 | COMPOSITIONS AND METHODS USING AN EPIGENETIC INHIBITOR | 2019-11-28 |
20190358266 | COMPOSITIONS OF BOTULINUM TOXIN AND PLATELET-RICH PLASMA AND THE THERAPEUTIC USE THEROF | 2019-11-28 |
20190358267 | VITRO PRE-CONDITIONED BONE MARROW-DERIVED MESENCHYMAL STEM CELLS AND USES THEREOF | 2019-11-28 |
20190358268 | Methods of Treating HIV Infection with Allogeneic CCR5 Null Umbilical Cord Blood Cells | 2019-11-28 |
20190358269 | COMBINATION THERAPY FOR A STABLE AND LONG TERM ENGRAFTMENT USING SPECIFIC PROTOCOLS FOR T/B CELL DEPLETION | 2019-11-28 |
20190358270 | PORIFERA-BASED THERAPEUTIC COMPOSITIONS FOR TREATING AND PREVENTING SKIN DISEASES | 2019-11-28 |
20190358271 | THERAPEUTIC USES OF AN INSECT POWDER | 2019-11-28 |
20190358272 | PREPARATION OF DRY FORMULATIONS OF DAIRY PROBIOTICS | 2019-11-28 |
20190358273 | PHARMACEUTICAL COMPOSITION AND FOOD COMPOSITION WITH STRAINS OF LACTIC ACID BACTERIA FOR IMPROVING OF KIDNEY DISEASE AND INHIBITING INFLAMMATION | 2019-11-28 |
20190358274 | METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS | 2019-11-28 |
20190358275 | PROBIOTIC COMPOSITIONS AND USES THEREOF | 2019-11-28 |
20190358276 | NOVEL THERAPEUTIC AGENT FOR PRIONOID DISEASES | 2019-11-28 |
20190358277 | ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING DEGRADATION FACTOR FOR EXTRACELLULAR MATRIX | 2019-11-28 |
20190358278 | FREEZE DRY PROCESS | 2019-11-28 |
20190358279 | COMPOSITIONS FROM HALOPHYTE PLANTS AND METHODS OF USE THEREOF | 2019-11-28 |
20190358280 | NEW COMPOSITIONS FOR THE TREATMENT OF ARTICULAR DISORDERS | 2019-11-28 |
20190358281 | Composition Comprising Retinol, a Precursor or a Reaction Product of it and a Plant Extract from at least one Chamomilla Plant for the Treatment of Cancer | 2019-11-28 |
20190358283 | COMPOSITION FOR PREVENTING OR TREATING CANCER | 2019-11-28 |
20190358284 | METHOD FOR PROMOTING HAIR GROWTH USING BANANA STAMEN EXTRACT | 2019-11-28 |
20190358285 | A METHOD OF FABRICATING AN ELECTRONIC POWER MODULE BY ADDITIVE MANUFACTURING, AND ASSOCIATED SUBSTRATE AND MODULE | 2019-11-28 |
20190358286 | METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING | 2019-11-28 |
20190358287 | PEPTIDE FOR IMPROVING MEMORY | 2019-11-28 |
20190358288 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ENVIRONMENTAL ENTEROPATHY | 2019-11-28 |
20190358289 | COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH PERMEABILITY OF INTESTINAL EPITHELIUM | 2019-11-28 |
20190358290 | Self Assembling Peptide Matrix for the Prevention of Esophageal Stricture After Endoscopic Dissection | 2019-11-28 |
20190358291 | Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy | 2019-11-28 |
20190358292 | COMPOSITIONS AND METHODS FOR LUNG REGENERATION | 2019-11-28 |
20190358293 | COMBINATION THERAPY FOR TREATING DISORDERS OF THE EAR | 2019-11-28 |
20190358294 | COMPOSITIONS AND METHODS RELATING TO MYOMAKER-INDUCED MUSCLE CELL FUSION | 2019-11-28 |
20190358295 | METHODS AND COMPOSITIONS FOR MODULATING ERYTHROPOIESIS | 2019-11-28 |
20190358296 | METHODS FOR TREATING METABOLIC DISORDERS USING FGF | 2019-11-28 |
20190358297 | ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM | 2019-11-28 |
20190358298 | COMPOSITIONS AND METHODS FOR INHIBITING THE BIOLOGICAL ACTIVITY OF SOLUBLE BIOMOLECULES | 2019-11-28 |
20190358299 | GLP-1R AGONISTS AND USES THEREOF | 2019-11-28 |
20190358300 | METHOD AND COMPOSITION FOR NOVEL USE OF IGF-1 AND GARCINOL TO INDUCE CLINICAL WEIGHT LOSS | 2019-11-28 |
20190358301 | PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIII | 2019-11-28 |
20190358302 | Recombinant Alpha-Galactosidase A For Treatment Of Fabry Disease | 2019-11-28 |
20190358303 | TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED HUMAN ALPHA-L-IDURONIDASE (IDUA) | 2019-11-28 |
20190358304 | ORAL DELIVERY OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) OR ANGIOTENSIN-(1-7)-BIOENCAPSULATED IN PLANT CELLS ATTENUATES PULMONARY HYPERTESNIONS, CARDIAC DYSFUNCTION AND DEVELOPMENT OF AUTOIMMUNE AND EXPOERIMENTALLY INDUCED OCULAR DISORDERS | 2019-11-28 |
20190358305 | AAV-BASED GENE THERAPY FOR GLAUCOMA | 2019-11-28 |
20190358306 | AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE | 2019-11-28 |
20190358307 | THERAPEUTIC AGENT FOR CEREBRAL INFARCTION | 2019-11-28 |
20190358308 | THROMBOXANE RECEPTOR-BASED VACCINE FOR MANAGING THROMBOGENESIS | 2019-11-28 |
20190358309 | Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology | 2019-11-28 |
20190358310 | METHOD FOR REDUCING SKATOLE AND/OR INDOLE IN ANIMALS | 2019-11-28 |
20190358311 | VACCINE FOR INTRAUTERINE DISEASE | 2019-11-28 |
20190358312 | ANTIGEN-ADJUVANT COUPLING REAGENTS AND METHODS OF USE | 2019-11-28 |
20190358313 | NEW FLAVIVIRUS VACCINE | 2019-11-28 |
20190358314 | NUCLEOSIDE-MODIFIED RNA FOR INDUCING AN IMMUNE RESPONSE AGAINST ZIKA VIRUS | 2019-11-28 |
20190358315 | POLIOVACCINE | 2019-11-28 |
20190358316 | INFECTIOUS BRONCHITIS VIRUS VACCINE USING NEWCASTLE DISEASE VIRAL VECTOR | 2019-11-28 |
20190358317 | Cytomegalovirus Surface Protein Complex for use in Vaccines and as a Drug Target | 2019-11-28 |
20190358318 | IMPROVED VACCINE COMPOSITIONS AND METHODS OF USE | 2019-11-28 |
20190358319 | LIPIDS AS SYNTHETIC VECTORS TO ENHANCE ANTIGEN PROCESSING AND PRESENTATION EX-VIVO IN DENDRITIC CELL THERAPY | 2019-11-28 |